Techdamentals
HUM · Humana Inc.Healthcare

What is Humana (HUM) stock worth?

Its intrinsic value, worked out four ways from Humana’s own reported numbers, against today’s price.
Fair value range
$515 – $630

Today’s price, $390, sits below the range. 31.9% below the $572.68 the four methods put it at.

UNDERVALUED
After hours $382.07 ▼ 2.03% (not used in the valuation)
This range was worked out on November 11, 2026 from the company's reported numbers. The price is live, and the verdict compares today's price with that range.
A fair value isn’t a one-time number. The valuation methods run on HUM’s reported numbers, which change with every quarterly earnings report, and this range is worked out again at least once a month. The price moves every day. So a stock that reads as cheap today can read as fair, or expensive, a few weeks from now. A free account keeps the latest range in front of you, and a phone alert tells you when the price moves into a part of the range you pick.

Inside HUM’s full analysis

The real sections, opened with your free account.

Why this verdict Free account

The 4 methods put Humana’s fair value around $573 a share.

The 4 methods, side by side Free account
Method 1
Method 2
Method 3
Method 4
The business, explained 2 open

Is it growing? Over the last 3 years, Humana's sales have grown about 12% a year. In its latest quarter (Q3 '26), sales were about 26% higher than the same quarter a year earlier.

Does it make money? Yes. Of every dollar of sales, Humana keeps about 13 cents after making the product, 2 cents after running the business and 1 cents as profit after everything, tax included.

HUM’s latest earningsHumana Inc.

Latest report: July to September 2026 (quarter ended Sep 30, 2026), reported Nov 6, 2026 before the open.

Earnings per share
−$0.70Beat
−$1.00 expected
Revenue
$41.2BIn line
$40.9B expected
Outlook
Above
full year earnings vs expected
Stock after report
+5.3%
S&P 500 +0.3%

Expectations are analysts’ averages as of Nov 5, 2026, before the report.

July to September 2026, in numbers
Earnings per share
$-0.70, above the $-1.00 analysts expected.
Revenue
$41 billion, up 26% from a year ago and up 0.7% from the quarter before.
Profit
$162 million. It keeps 0¢ of every sales dollar as profit, down from 1¢ a year ago.

From the company's quarterly statements through Sep 30, 2026.

What the company expects next, in its own words
Humana revises its GAAP EPS guidance for the year ending December 31, 2026 (FY 2026) to 'at least $15.09' from 'at least $6.52', while raising its Adjusted EPS guidance to 'at least $9.50' from the previous guidance of 'at least $9.00'.

From the earnings release filed Nov 6, 2026.

The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how HUM moved after its last eight reports.

See HUM’s full earnings read, free →
Not HUM? Value the stock you care about:
Educational tool, not investment advice. These are automated estimates from third-party data, impersonal and not tailored to anyone's situation. Data can be inaccurate and model assumptions can be wrong. We are not a registered investment adviser or broker-dealer. Always do your own research. See our methodology and terms.